The slip
PARKINSON RECEIPTno. 9841
25 Oct 2026, 15:05 UTCdopamine neurons, braak
predictionMAPK8IP1 in dopamine neurons tracks Braak Lewy-body stage
registereddd1d8805c766fe74
discovery-0.39 p=0.299 n=9
replication-0.21 p=0.581 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.39, p 0.299)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT3b9d1c04089fd94ed6ca4584…
follows 4108bd420f58…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9841: MAPK8IP1 in dopamine neurons, braak
- power
- full sample -0.41 (p 0.093, n 18), 95% CI -0.73 to +0.07. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.41 (p 0.093, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.49 (p 0.037, n 18). not the mix.
- skeptic
- leave-one-out range -0.62 to -0.36, sign flips 0; without severely affected donors -0.41 (p 0.093, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.59 (p 0.0092, n 18) vs -0.41 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MAPK8IP1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MAPK8IP1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.18 p 0.534 (needs p < 2.2e-4)